NCT05682352View on ClinicalTrials.gov

Investigating the Safety of LEO 158968 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

February 7, 2023

Primary Completion Date

May 7, 2024

Study Completion Date

August 1, 2024

Conditions

Healthy Volunteers

Interventions

DRUG

LEO 158968

IV infusion or SC injection

DRUG

Placebo

IV infusion or SC injection

DRUG

LEO 158968

SC injection

DRUG

Placebo

SC injection

Trial Locations (1)

9728

LEO Pharma Investigational Site, Groningen

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY